Clinical Trial Update: Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bilateral middle meningeal artery lidocaine infusion for chronic debilitating migraines is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Northwell Health | Conditions: Migraine | Phase 2 | Status: RECRUITING